S - Gastrointestinal And Liver Disease 12th Edition

You're looking for information on the 12th edition of "Sleisenger and Fordtran's Gastrointestinal and Liver Disease". Here's what I found:

Overview

Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a comprehensive medical textbook that provides in-depth coverage of gastrointestinal and liver diseases. The 12th edition is the latest version of this renowned textbook.

Key Features

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease features:

  1. Updated content: The latest information on the diagnosis, treatment, and management of gastrointestinal and liver diseases.
  2. New chapters: Additional chapters on topics such as gut microbiome, intestinal failure, and gastrointestinal manifestations of systemic diseases.
  3. Reorganized sections: Streamlined sections on gastrointestinal infections, inflammatory bowel disease, and liver disease.
  4. Increased focus on therapeutics: Expanded coverage of pharmacological and endoscopic treatments for gastrointestinal and liver diseases.
  5. Enhanced illustrations: High-quality images, diagrams, and charts to aid understanding and visualization.

Chapter Outline

The 12th edition is divided into several sections, including:

  1. Part 1: Symptoms, Signs, and Diagnostic Methods
    • Chapter 1: Approach to the Patient with Gastrointestinal Disease
    • Chapter 2: Gastrointestinal Endoscopy
    • Chapter 3: Radiology of the Gastrointestinal Tract
  2. Part 2: Esophageal Disease
    • Chapter 4: Diseases of the Esophagus
  3. Part 3: Stomach and Duodenum
    • Chapter 5: Diseases of the Stomach and Duodenum
  4. Part 4: Small and Large Intestine
    • Chapter 6: Diseases of the Small Intestine
    • Chapter 7: Diseases of the Large Intestine
  5. Part 5: Liver Disease
    • Chapter 8: Liver Disease

Target Audience

This textbook is aimed at:

  1. Gastroenterologists: Specialists in gastroenterology and hepatology.
  2. Internal medicine physicians: Physicians who want to stay up-to-date on gastrointestinal and liver diseases.
  3. Residents and fellows: Trainees in gastroenterology, internal medicine, and surgery.
  4. Medical students: Students interested in gastroenterology and hepatology.

Availability

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is available in various formats, including:

  1. Hardcover: Print book available on online retailers like Amazon.
  2. E-book: Digital version available on platforms like Elsevier's ExpertConsult.

If you're looking for more specific information or would like to purchase a copy, I recommend visiting the Elsevier website or checking with your local medical bookstore.

Sleisenger and Fordtran's Gastrointestinal and Liver Disease: 12th Edition – The Gold Standard in Gastroenterology

For over fifty years, one textbook has stood above all others as the definitive source for clinical gastroenterology and hepatology. The release of Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition, continues this legacy, providing a comprehensive, evidence-based foundation for clinicians, fellows, and residents worldwide.

In an era where medical knowledge evolves at a breakneck pace, the 12th edition arrives as an essential update, bridging the gap between cutting-edge research and bedside practice. What’s New in the 12th Edition?

The 12th edition isn't just a reprint; it is a thorough overhaul designed to reflect the current landscape of digestive health. 1. Advanced Microbiome Insights

Our understanding of the human gut microbiome has exploded. This edition integrates the latest science on how microbial communities influence everything from Inflammatory Bowel Disease (IBD) to metabolic disorders and liver health. 2. Precision Medicine and Genetics

The shift toward personalized care is a major theme. The text explores genetic markers, biological therapies, and targeted treatments that allow physicians to move beyond a "one size fits all" approach to complex diseases. 3. Expanded Hepatology Coverage

With the rise of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—formerly NAFLD—and breakthroughs in Hepatitis C and cirrhosis management, the liver sections have been significantly expanded to provide the most current clinical pathways. 4. Minimally Invasive Innovations

The 12th edition highlights the latest in diagnostic and therapeutic endoscopy, including EUS (Endoscopic Ultrasound) and ERCP, as well as the expanding role of robotic surgery in gastrointestinal care. Core Features That Set It Apart

Multidisciplinary Approach: Content is curated by a world-class team of editors (Mark Feldman, Lawrence S. Friedman, and Lawrence J. Brandt) and hundreds of expert contributors, ensuring a balanced view from both medical and surgical perspectives.

Radiology and Pathology Integration: Thousands of high-quality illustrations, anatomical drawings, and clinical photos help clinicians correlate symptoms with visual findings.

Summary Tables and Algorithms: For the busy practitioner, the 12th edition utilizes clear, concise tables and treatment algorithms that make decision-making faster and more accurate.

Comprehensive Evidence Base: Every chapter is backed by the most recent clinical trials and consensus guidelines, making it the primary reference for board exams and certification. Why Every GI Specialist Needs the 12th Edition

Whether you are a seasoned gastroenterologist or a trainee preparing for the boards, this textbook serves as a "living" document of the field. It covers the full spectrum of digestive health:

Esophageal and Gastric Disorders: From GERD and motility issues to peptic ulcer disease.

Small and Large Intestine: Deep dives into Celiac disease, Crohn’s, Ulcerative Colitis, and IBS.

Pancreatico-Biliary System: Comprehensive management of pancreatitis and gallstone disease.

Liver Disease: Updates on transplantation, autoimmune hepatitis, and oncology. Conclusion

Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition remains the most trusted encyclopedia of the digestive system. By combining foundational pathophysiology with the latest technological and pharmacological breakthroughs, it ensures that practitioners are equipped to provide the highest level of patient care.

In the complex and ever-changing world of gastroenterology, this is the one resource you cannot afford to be without.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease

remains the definitive "gold standard" reference for the field. Scheduled for release in December 2025, this edition transitions to a new senior editorial team led by Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Key Updates & New Features

This edition integrates the latest scientific breakthroughs with practical clinical management across its two volumes:

Emerging Medical Contexts: Includes new chapters specifically addressing the gastrointestinal and hepatic manifestations of COVID-19.

Technological Integration: New coverage of Artificial Intelligence (AI) in endoscopy for enhanced detection of GI cancers and improved diagnostic accuracy. s gastrointestinal and liver disease 12th edition

Novel Therapeutic Areas: New chapters on cancer immunotherapy-induced enterocolitis and hepatitis, and a dedicated section on neoplasia involving multiple organs.

Liver Disease Advancements: Expanded focus on MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), formerly NAFLD, along with new chapters on non-invasive fibrosis assessment and nutrition in liver disease.

Practical Tools: Features over 1,100 full-color illustrations and more than 20 procedural videos accessible via the included eBook at Elsevier. Product Details Information Release Date December 10, 2025 Format 2-Volume Set (Hardcover or Digital) Page Count Approximately 2,560 pages Publisher Elsevier Health ISBN-13 978-0443116575

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

Unlocking the Secrets of Gastrointestinal and Liver Diseases: A Comprehensive Review of the 12th Edition

For decades, Sleisenger and Fordtran's Gastrointestinal and Liver Disease has been the go-to reference for gastroenterologists, hepatologists, and medical professionals seeking in-depth knowledge on the diagnosis, treatment, and management of gastrointestinal and liver disorders. The 12th edition of this esteemed textbook continues to uphold its reputation as a trusted and authoritative resource, offering cutting-edge insights and practical guidance for healthcare providers.

What's New in the 12th Edition?

The latest edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease boasts significant updates, including:

  1. Expanded coverage of liver diseases: A new section dedicated to liver transplantation, reflecting the growing importance of this therapeutic option for patients with end-stage liver disease.
  2. Advances in gastrointestinal cancer screening: Updated guidelines for colorectal cancer screening and prevention, highlighting the latest evidence on the use of fecal immunochemical tests and colonoscopy.
  3. Emerging therapies for IBD: A comprehensive review of novel treatments for inflammatory bowel disease (IBD), including biologic agents and small molecules.
  4. Increased focus on gut microbiome: A dedicated chapter on the gut microbiome and its implications for gastrointestinal health and disease.

Key Features of the 12th Edition

  1. Comprehensive and authoritative content: Written by an international team of experts, this textbook provides thorough coverage of gastrointestinal and liver diseases, from basic science to clinical practice.
  2. Richly illustrated: Over 400 illustrations, including endoscopic images, radiographic studies, and histopathology slides, to facilitate understanding and diagnosis.
  3. Clinical pearls and case studies: Real-world examples and expert advice to guide clinicians in making informed decisions at the bedside.
  4. Updated references and bibliographies: A comprehensive list of references, reflecting the latest research and clinical guidelines.

Who Will Benefit from This Textbook?

  1. Gastroenterologists and hepatologists: A valuable resource for specialists seeking to stay current with the latest developments in their field.
  2. Internal medicine physicians: A comprehensive reference for primary care physicians managing patients with gastrointestinal and liver complaints.
  3. Trainees and residents: A trusted guide for gastroenterology and hepatology fellows, as well as internal medicine residents.
  4. Nurses and allied healthcare professionals: A useful resource for those involved in the care of patients with gastrointestinal and liver diseases.

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease remains an essential resource for anyone involved in the diagnosis, treatment, and management of gastrointestinal and liver disorders. With its comprehensive coverage, rich illustrations, and clinical pearls, this textbook continues to set the standard for excellence in gastroenterology and hepatology.

Overview of S. Gastrointestinal and Liver Disease 12th Edition

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a comprehensive reference text that provides authoritative guidance on the diagnosis, treatment, and management of gastrointestinal and liver disorders. This esteemed textbook has been a trusted resource for gastroenterologists, hepatologists, and other healthcare professionals for over 50 years.

Key Features of the 12th Edition

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease has been thoroughly revised and updated to reflect the latest advances in the field. Some of the key features of this edition include:

  • Comprehensive coverage: The text covers a wide range of gastrointestinal and liver disorders, including esophageal, gastric, small intestine, and large intestine disorders, as well as liver diseases, pancreatic disorders, and nutritional disorders.
  • Expert authorship: The text is written by a team of renowned experts in the field of gastroenterology and hepatology, ensuring that the information is accurate, up-to-date, and authoritative.
  • Clear and concise presentation: The text is presented in a clear and concise manner, making it easy to read and understand, even for complex topics.
  • Richly illustrated: The text is richly illustrated with over 400 illustrations, including endoscopic images, radiographic images, and histopathologic images, which help to enhance understanding and diagnosis.

Major Updates in the 12th Edition

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease includes several major updates, including:

  • New chapters: New chapters have been added on topics such as the gut microbiome, gastrointestinal cancer, and nutrition and gastrointestinal disease.
  • Updated diagnostic and therapeutic guidelines: The text includes updated diagnostic and therapeutic guidelines for a range of gastrointestinal and liver disorders, including gastroesophageal reflux disease, inflammatory bowel disease, and liver cirrhosis.
  • Increased focus on molecular and cellular biology: The text places increased emphasis on the molecular and cellular biology of gastrointestinal and liver diseases, providing a deeper understanding of the underlying mechanisms of disease.

Target Audience

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is an essential resource for:

  • Gastroenterologists: Gastroenterologists will find the text to be a comprehensive and authoritative reference guide for the diagnosis, treatment, and management of gastrointestinal and liver disorders.
  • Hepatologists: Hepatologists will appreciate the text's detailed coverage of liver diseases, including diagnostic and therapeutic guidelines.
  • Internal medicine physicians: Internal medicine physicians will find the text to be a valuable resource for managing patients with gastrointestinal and liver disorders.
  • Trainees: Trainees in gastroenterology, hepatology, and internal medicine will find the text to be an invaluable resource for learning about gastrointestinal and liver diseases.

Overall, the 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease is a comprehensive and authoritative reference text that provides healthcare professionals with the knowledge and expertise needed to diagnose, treat, and manage gastrointestinal and liver disorders.

Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 12th Edition, is widely considered the definitive "gold standard" reference for gastroenterology. Published in late 2025 and early 2026, this latest edition is managed by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Key Updates and "What’s New"

The 12th edition reflects rapid advancements in GI and hepatology, introducing several critical updates:

Modern Pathology Chapters: New dedicated chapters address Gastrointestinal and Hepatic Manifestations of Coronavirus Infection (COVID-19) and Enterocolitis and Hepatitis Induced by Cancer Immunotherapy.

AI and Technology: Features expanded discussions on the use of Artificial Intelligence (AI) in endoscopy for improved detection of GI cancers.

Liver Disease Evolution: Significant updates to MASLD (Metabolic dysfunction-associated steatotic liver disease, formerly NAFLD) and new treatments for viral hepatitis and autoimmune liver diseases.

Expanded Sections: A new section on Neoplasia Involving Multiple Organs and broader coverage of inflammatory bowel disorders (IBD). Practical Learning Features

Designed for both deep study and quick clinical reference, the 12th edition includes:

Visual Aids: Over 1,100 full-color illustrations and more than 20 procedural videos covering endoscopic techniques like balloon dilatation and stent placement.

Clinical Algorithms: Quick-reference algorithms are used throughout to summarize complex decision-making and patient management.

Templated Format: A consistent, templated chapter design allows for high-speed scannability during busy clinical shifts.

Enhanced eBook: Purchases typically include an eBook version with searchable text, highlighting tools, and read-aloud capabilities.

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

Title: An Evolving Paradigm: A Review of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 12th Edition

Abstract For over four decades, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease has served as the definitive reference for the diagnosis and management of digestive disorders. The release of the 12th edition arrives at a critical juncture in medical history, bridging the gap between classical pathophysiology and the rapid advancements in immunology, genomics, and interventional endoscopy. This paper provides a comprehensive review of the 12th edition, analyzing its structural organization, the integration of current clinical guidelines, and its adaptation to the digital age of evidence-based medicine. Special attention is given to the text's expanded coverage of the microbiome, liver transplantation, and the implications of the COVID-19 pandemic on gastroenterological practice.

1. Introduction The field of gastroenterology is characterized by a unique duality: it is deeply rooted in the mechanical understanding of hollow organ systems while simultaneously standing at the forefront of biotechnological innovation. Since its inception, Sleisenger and Fordtran has been the gold standard text for translating complex physiological mechanisms into clinical practice. The 12th edition, published against the backdrop of a global pandemic and an explosion of biological therapeutics, faces the challenge of maintaining its encyclopedic depth while remaining clinically relevant. This paper explores how the 12th edition meets this challenge, serving not merely as a textbook, but as a comprehensive roadmap for the modern gastroenterologist. You're looking for information on the 12th edition

2. Structure and Scope The 12th edition maintains the two-volume format familiar to its readership, organized anatomically and physiologically. However, a notable shift in this edition is the streamlined organization of sections to facilitate rapid information retrieval. The text is divided into distinct biological and clinical sections:

  • Biological and Physiological Basis: This section continues to excel in explaining the mechanics of the gut, from the molecular biology of ion transport to the complex neuromuscular coordination of motility.
  • Clinical Management: The bulk of the text follows an organ-system approach (Esophagus, Stomach, Small Intestine, Colon, Liver, Biliary Tree, and Pancreas).

The editors have successfully navigated the tension between print limitations and the vast expansion of medical knowledge. The inclusion of over 1,000 full-color illustrations and endoscopic images is not merely aesthetic but pedagogical, providing visual correlates for the pathological descriptions found in the text.

3. Key Updates and Advancements

3.1 The Microbiome and Environmental Factors Perhaps the most significant update in the 12th edition is the deepened focus on the gut microbiome. Previous editions introduced the concept; the 12th edition integrates it into the pathogenesis of numerous conditions. The text thoroughly revisits the role of dysbiosis in Inflammatory Bowel Disease (IBD), irritable bowel syndrome (IBS), and metabolic syndrome. Furthermore, the editors have expanded the section on environmental risk factors, reflecting current literature on diet, antibiotics, and their long-term impact on gut health.

3.2 Advances in Therapeutics and Endoscopy The "Therapeutic" sections have undergone substantial revision. The management of Hepatitis C, a rapidly evolving field, is updated to reflect the pan-genotypic direct-acting antivirals (DAAs) that have revolutionized cure rates. Similarly, the section on IBD has been overhauled to include the latest biologics and small molecule inhibitors (JAK inhibitors), offering clear algorithms for step-up versus top-down therapeutic approaches. Interventional endoscopy receives significant attention, with expanded chapters on endoscopic ultrasound (EUS), endoscopic submucosal dissection (ESD), and endoscopic bariatric therapies. These chapters bridge the gap between gastroenterology and surgery, highlighting the shift toward minimally invasive treatments.

3.3 Hepatology and Transplantation Hepatology continues to grow in complexity. The 12th edition offers robust updates on Non-Alcoholic Fatty Liver Disease (NAFLD) and its progressive counterpart, Non-Alcoholic Steatohepatitis (NASH), acknowledging the rising global prevalence of metabolic syndrome. The liver transplantation protocols are updated to reflect current organ allocation policies (MELD score evolution) and post-transplant immunosuppression strategies, providing a vital resource for hepatologists and surgeons alike.

3.4 The Impact of COVID-19 A distinguishing feature of this edition is its inclusion of data regarding the SARS

The 12th Edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease

, scheduled for release in December 2025, is a comprehensive two-volume masterwork that serves as the definitive reference for gastroenterology and hepatology. Key Highlights of the 12th Edition

New Editorial Team: Guided by Raymond T. Chung, David T. Rubin, and C. Mel Wilcox.

Expanded Clinical Topics: Includes updated discussions on eosinophilic disorders, MASLD (Metabolic dysfunction-associated steatotic liver disease), and the latest treatments for inflammatory bowel disorders (IBD).

Technological Advances: Features the use of AI in endoscopy for GI cancer detection and new sections on molecular diagnostics.

Modern Pathology: New chapters covering COVID-19 manifestations in the GI tract and liver, as well as cancer immunotherapy-induced enterocolitis and hepatitis.

Multimedia Integration: Over 1,100 full-color illustrations and more than 20 procedural videos are included in the enhanced eBook version. Table of Contents (Summary of Major Parts)

The textbook is organized logically across 11 primary sections comprising 132 chapters:

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

12th edition Sleisenger and Fordtran's Gastrointestinal and Liver Disease , published by

in December 2025, represents a significant update to what remains the definitive reference for gastroenterology and hepatology. Key Updates & New Chapters

The 12th edition introduces essential topics reflecting modern medical challenges and technological advancements: Viral and Autoimmune Liver Disease

: Features updated treatment protocols and expanded discussions on

(metabolic dysfunction-associated steatotic liver disease, formerly NAFLD). Artificial Intelligence (AI)

: New coverage of AI applications in endoscopy to enhance the detection of gastrointestinal cancers. COVID-19 Impact

: A dedicated new chapter on the gastrointestinal and hepatic manifestations of coronavirus infections. Immunotherapy Complications

: New insights into enterocolitis and hepatitis induced by cancer immunotherapy. Inflammatory Bowel Disorders (IBD)

: Expanded array of new biological treatments and small molecules. US Elsevier Health Enhanced Clinical Utility Editorial Leadership

: Guided by a new senior team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox. Decision-Making Tools : Includes over 1,100 full-color illustrations

and quick-reference algorithms to streamline clinical diagnosis and patient management. Multimedia Content : Provides access to more than

of advanced endoscopic procedures, such as balloon dilatation and stent placement. Comprehensive Scope

: Covers the full spectrum from basic science and anatomy to advanced therapeutic techniques like liver transplantation and molecular diagnostics. US Elsevier Health Product Specifications Release Date December 10, 2025 (varies by region to Dec 24) 2-Volume Set (Hardcover) or E-Book Page Count Approximately 2,536–2,560 pages Available at companion book or details on the new AI endoscopy techniques

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Sleisenger and Fordtran's Gastrointestinal and Liver Disease - 2 Volume Set - 12th Edition | Elsevier Shop

The 12th edition of Sleisenger and Fordtran's Gastrointestinal and Liver Disease

was released on December 10, 2025. As the definitive reference for gastroenterology and hepatology for over 50 years, this two-volume masterwork continues to provide comprehensive coverage of pathophysiology, diagnosis, and management. Key Updates and New Features

The 12th edition introduces significant content updates reflecting the latest advancements in the field:

New Editorial Team: The work is now guided by senior editors Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox.

Expanded Clinical Topics: Features new and expanded discussions on MASLD (metabolic dysfunction-associated steatotic liver disease), eosinophilic disorders, and the array of new treatments for IBD. Updated content : The latest information on the

New Chapters: Includes specialized chapters on gastrointestinal and hepatic manifestations of COVID-19, as well as enterocolitis and hepatitis induced by cancer immunotherapy.

AI Integration: Coverage of the use of artificial intelligence in endoscopy for the improved detection of gastrointestinal cancers.

Visual and Technical Aids: The edition includes over 1,100 full-color illustrations, clinically practicable algorithms, and more than 20 procedural videos. Book Specifications Publisher Elsevier Publication Date December 10, 2025 Page Count 2,560 pages Format 2-Volume Set (Hardcover) or eBook ISBN-13 978-0443116575

The 12th edition remains available for purchase at major retailers like Amazon, Barnes & Noble, and VitalSource.

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

12th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease

(published December 2025) remains the gold-standard reference for gastroenterology and hepatology. Led by a new senior editorial team including Drs. Raymond T. Chung, David T. Rubin, and C. Mel Wilcox, this two-volume set integrates basic science with the latest clinical technologies and treatments. Core Themes and New Chapters

The 12th edition introduces specific chapters that address contemporary global health challenges and evolving scientific understanding:

Gastrointestinal and Hepatic Manifestations of Coronavirus Infection

: A new chapter dedicated to the long-term and acute impacts of COVID-19 on the digestive system. Cancer Immunotherapy Side Effects

: A new chapter on Enterocolitis and Hepatitis induced by cancer immunotherapy, reflecting the rise of biological treatments in oncology. Microbiota and Probiotics

: Expanded focus on the enteric microbiota, fecal microbiota transplantation, and the role of the gut-brain axis in disease. Artificial Intelligence (AI)

: New discussions on using AI in endoscopy to enhance the detection of gastrointestinal cancers. Major Clinical Updates Liver Disease Nomenclature : Transition to the term

(metabolic dysfunction-associated steatotic liver disease), formerly known as non-alcoholic fatty liver disease (NAFLD). Advanced Hepatology

: Detailed updates on the treatment of viral hepatitis, autoimmune liver diseases, and the management of cirrhosis complications. Inflammatory Bowel Disease (IBD)

: Extensive new data on biologics and novel small molecules for treating and preventing IBD recurrences. Obesity Management

: Updated sections on the surgical and endoscopic treatment of obesity, reflecting the shift toward minimally invasive interventions. Structure and Educational Features Templated Format

: Organized into 11 sections and 132 chapters for consistent, quick information retrieval. Visual Aids

: Contains more than 1,100 full-color illustrations and dozens of procedural videos accessible via the Elsevier Expert Consult eBook Clinical Algorithms

: High-speed scannable decision-making tools that summarize patient management for complex GI cases. specific summary of one of the new clinical topics like MASLD?

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Sleisenger and Fordtran's Gastrointestinal and Liver Disease

12th Edition Sleisenger and Fordtran's Gastrointestinal and Liver Disease released on December 10, 2025

. This comprehensive update to the "definitive GI reference" introduces several new clinical chapters and reflects major shifts in the management of digestive and hepatic conditions. Key Updates & New Content The latest edition, edited by experts like Raymond T. Chung David T. Rubin , features significant expansions: Novel Pathologies: New chapters covering Gastrointestinal and Hepatic Manifestations of COVID-19 Enterocolitis and Hepatitis Induced by Cancer Immunotherapy Advanced Technology: Detailed discussion on the use of AI in endoscopy to improve the detection of GI cancers. Updated Terminology: Comprehensive coverage of

(Metabolic dysfunction-associated Steatotic Liver Disease), reflecting the shift from the former NAFLD nomenclature. Therapeutic Advances: Updates on new treatments for viral hepatitis

, autoimmune liver diseases, and the expanding array of biologics for inflammatory bowel disorders (IBD) Clinical Utility

Designed for both seasoned clinicians and fellows, the 12th edition includes: Visual Learning: 1,000 illustrations and photographs, with 400 in full color. Procedural Content: 35 new procedural videos through the digital version. Decision Support: quick-reference algorithms to assist in bedside clinical decision-making. Google Books

The book is available through major medical retailers such as Barnes & Noble new management algorithms included for a specific disease, such as

This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more

Sleisenger and Fordtran's Gastrointestinal and Liver Disease - Elsevier

Why It Remains the "Gold Standard"

Unlike many review books that condense information into bullet points, Sleisenger and Fordtran offers depth. It does not merely state guidelines (e.g., "Administer drug X for condition Y"); it explains the pharmacokinetics, the clinical trial data behind the guideline, and the potential complications.

This edition is particularly praised for its balanced approach to evidence-based medicine. Where evidence is strong, the text is directive. Where evidence is lacking or controversial, the authors present the data neutrally, allowing the clinician to make informed decisions.

Key Points Boxes

Each major section begins with a "Key Points" summary—perfect for rapid clinical decision-making during a busy clinic day. For example, the chapter on acute pancreatitis now opens with a bulleted list of the revised Atlanta classification, indications for early ERCP, and fluid resuscitation targets (goal-directed vs. aggressive).

Part X: Emerging & Technology

  1. Artificial Intelligence in Gastroenterology (NEW: polyp detection, IBD risk prediction, wireless capsule reading)
  2. Advanced Endoscopy (new: EUS-RFA, through-the-needle microforceps)
  3. Gene & Cell Therapies (new: CAR-T for liver metastases, CRISPR for ATTR amyloidosis)

Who Should Use This 12th Edition?

Structural and Pedagogical Enhancements

The 12th edition retains the beloved "Sleisenger" format but adds modern learning tools:

Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, 12th Edition (2020)

Part V: Colon & Anorectum

  1. Irritable Bowel Syndrome (IBS) (major rewrite: Rome V criteria preview, low-FODMAP, rifaximin)
  2. Inflammatory Bowel Disease (IBD) – two chapters:
    • 16A: UC & Crohn’s – Medical Therapy (new: ozanimod, upadacitinib, risankizumab)
    • 16B: IBD – Surgical & Endoscopic Management (new: strictureplasty, J-pouch salvage)
  3. Colorectal Cancer Screening (new: mt-sDNA, blood-based assays, AI-assisted colonoscopy)

Overview

Often referred to simply as Sleisenger and Fordtran’s, the 12th edition remains the definitive, encyclopedic reference for physicians, fellows, and residents in gastroenterology and hepatology. Published in 2020 by Elsevier, this two-volume set continues the legacy of providing comprehensive, evidence-based, and clinically actionable information on the entire spectrum of digestive disorders. The 12th edition arrives at a time of rapid advancements in gut microbiome research, immunotherapy for liver disease, and minimally invasive endoscopic techniques, all of which are thoroughly integrated into this update.